Prolonged morphine treatment alters δ opioid receptor post-internalization trafficking

British Journal of Pharmacology

Volumn 172, Issue 2, 2015, Pages 615-629

  Ong, E W ^a,b   Xue, L ^a   Olmstead, M C ^a   Cahill, C M ^a,b  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

DAMGO; deltorphin II; dorsal root ganglia; internalization; morphine; SDM 25N; SNC80; trafficking; opioid receptor; opioid receptor

Indexed keywords

4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; DELTA OPIATE RECEPTOR; DELTORPHIN II; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; MORPHINE; MU OPIATE RECEPTOR; OPIATE AGONIST; UNCLASSIFIED DRUG; 4-(ALPHA-(4-ALLYL-2,5-DIMETHYL-1-PIPERAZINYL)-3-METHOXYBENZYL)-N,N-DIETHYLBENZAMIDE; BENZAMIDE DERIVATIVE; DELTORPHIN II, ALA(2)-; NALTREXONE; NARCOTIC ANALGESIC AGENT; OLIGOPEPTIDE; PIPERAZINE DERIVATIVE; SDM 25N;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL SURFACE; CONTROLLED STUDY; DRUG EFFECT; INTERNALIZATION; MALE; NERVE CELL CULTURE; NONHUMAN; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; PROTEIN TRANSPORT; RAT; SPINAL GANGLION; AGONISTS; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; KNOCKOUT MOUSE; METABOLISM; NERVE CELL; SPRAGUE DAWLEY RAT;

ANALGESICS, OPIOID; ANIMALS; BENZAMIDES; CELLS, CULTURED; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; GANGLIA, SPINAL; MALE; MICE, KNOCKOUT; MORPHINE; NALTREXONE; NEURONS; OLIGOPEPTIDES; PIPERAZINES; PROTEIN TRANSPORT; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU;

EID: 84920179109     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12761     Document Type: Article

References (70)

1. Abul-Husn NS, Sutak M, Milne B, Jhamandas K, (2007). Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of mu- and delta-opioid receptor antagonists. Br J Pharmacol 151: 877-887.
2. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. and CGTP Collaborators (2013). The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors. Br J Pharmacol 170: 1459-1581.
3. Arvidsson U, Riedl M, Chakrabarti S, Lee JH, Nakano A, Dado RJ, et al. (1995). Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord. J Neurosci 15: 3328-3341.
4. Audet N, Paquin-Gobeil M, Landry-Paquet O, Schiller PW, Piñeyro G, (2005). Internalization and Src activity regulate the time course of ERK activation by delta opioid receptor ligands. J Biol Chem 280: 7808-7816.
5. Audet N, Galés C, Archer-Lahlou E, Vallières M, Schiller PW, Bouvier M, et al. (2008). Bioluminescence resonance energy transfer assays reveal ligand-specific conformational changes within preformed signaling complexes containing delta-opioid receptors and heterotrimeric G proteins. J Biol Chem 283: 15078-15088.
6. Audet N, Charfi I, Mnie-Filali O, Amraei M, Chabot-Doré A-J, Millecamps M, et al. (2012). Differential association of receptor-Gβγ complexes with β-arrestin2 determines recycling bias and potential for tolerance of δ opioid receptor agonists. J Neurosci 32: 4827-4840.
7. von Banchet GS, Richter J, Hückel M, Rose C, Bräuer R, Schaible H-G, (2007). Fibroblast-like synovial cells from normal and inflamed knee joints differently affect the expression of pain-related receptors in sensory neurones: a co-culture study. Arthritis Res Ther 9: R6.
8. Beaudry H, Dubois D, Gendron L, (2011). Activation of spinal mu- and delta-opioid receptors potently inhibits substance P release induced by peripheral noxious stimuli. J Neurosci 31: 13068-13077.
9. Bernard V, Décossas M, Liste I, Bloch B, (2006). Intraneuronal trafficking of G-protein-coupled receptors in vivo. Trends Neurosci 29: 140-147.
10. Blomeley CP, Bracci E, (2011). Opioidergic interactions between striatal projection neurons. J Neurosci 31: 13346-13356.
11. Cahill CM, Morinville A, Lee MC, Vincent JP, Collier B, Beaudet A, (2001). Prolonged morphine treatment targets delta opioid receptors to neuronal plasma membranes and enhances delta-mediated antinociception. J Neurosci 21: 7598-7607.
12. Cahill CM, Holdridge S V, Morinville A, (2007). Trafficking of delta-opioid receptors and other G-protein-coupled receptors: implications for pain and analgesia. Trends Pharmacol Sci 28: 23-31.
13. Chen W, Song B, Lao L, Pérez OA, Kim W, Marvizón JCG, (2007). Comparing analgesia and mu-opioid receptor internalization produced by intrathecal enkephalin: requirement for peptidase inhibition. Neuropharmacology 53: 664-676.
14. Chieng B, Christie MJ, (2009). Chronic morphine treatment induces functional delta-opioid receptors in amygdala neurons that project to periaqueductal grey. Neuropharmacology 57: 430-437.
15. Décaillot FM, Rozenfeld R, Gupta A, Devi LA, (2008). Cell surface targeting of mu-delta opioid receptor heterodimers by RTP4. Proc Natl Acad Sci U S A 105: 16045-16050.
16. Drake MT, Shenoy SK, Lefkowitz RJ, (2006). Trafficking of G protein-coupled receptors. Circ Res 99: 570-582.
17. Erbs E, Faget L, Scherrer G, Matifas A, Filliol D, Vonesch J-L, et al. (2014). A mu-delta opioid receptor brain atlas reveals neuronal co-occurrence in subcortical networks. Brain Struct Funct. [Epub ahead of print].
18. Fan T, Varghese G, Nguyen T, Tse R, O'Dowd BF, George SR, (2005). A role for the distal carboxyl tails in generating the novel pharmacology and G protein activation profile of mu and delta opioid receptor hetero-oligomers. J Biol Chem 280: 38478-38488.
19. Fields H, Emson P, Leigh B, Gilbert R, (1980). Multiple opiate receptor sites on primary afferent fibres. Nature 284: 351-353.
20. Filliol D, Ghozland S, Chluba J, Martin M, Matthes HW, Simonin F, et al. (2000). Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses. Nat Genet 25: 195-200.
21. French AP, Mills S, Swarup R, Bennett MJ, Pridmore TP, (2008). Colocalization of fluorescent markers in confocal microscope images of plant cells. Nat Protoc 3: 619-628.
22. Gendron L, Lucido AL, Mennicken F, O'Donnell D, Vincent J-P, Stroh T, et al. (2006). Morphine and pain-related stimuli enhance cell surface availability of somatic delta-opioid receptors in rat dorsal root ganglia. J Neurosci 26: 953-962.
23. George SR, Fan T, Xie Z, Tse R, Tam V, Varghese G, et al. (2000). Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. J Biol Chem 275: 26128-26135.
24. Gomes I, Jordan BA, Gupta A, Trapaidze N, Nagy V, Devi LA, (2000). Heterodimerization of mu and delta opioid receptors: a role in opiate synergy. J Neurosci 20: RC110.
25. Gomes I, Gupta A, Filipovska J, Szeto HH, Pintar JE, Devi LA, (2004). A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia. Proc Natl Acad Sci U S A 101: 5135-5139.
26. Groer CE, Tidgewell K, Moyer RA, Harding WW, Rothman RB, Prisinzano TE, et al. (2007). An opioid agonist that does not induce micro-opioid receptor-arrestin interactions or receptor internalization. Mol Pharmacol 71: 549-557.
27. Gupta A, Mulder J, Gomes I, Rozenfeld R, Bushlin I, Ong E, et al. (2010). Increased abundance of opioid receptor heteromers after chronic morphine administration. Sci Signal 3: ra54.
28. Hanyaloglu AC, von Zastrow M, (2008). Regulation of GPCRs by endocytic membrane trafficking and its potential implications. Annu Rev Pharmacol Toxicol 48: 537-568.
29. Hasbi A, Nguyen T, Fan T, Cheng R, Rashid A, Alijaniaram M, et al. (2007). Trafficking of preassembled opioid mu-delta heterooligomer-Gz signaling complexes to the plasma membrane: coregulation by agonists. Biochemistry 46: 12997-13009.
30. He L, Kim JA, Whistler JL, (2009). Biomarkers of morphine tolerance and dependence are prevented by morphine-induced endocytosis of a mutant mu-opioid receptor. FASEB J 23: 4327-4334.
31. He S-Q, Zhang Z-N, Guan J-S, Liu H-R, Zhao B, Wang H-B, et al. (2011). Facilitation of μ-opioid receptor activity by preventing δ-opioid receptor-mediated codegradation. Neuron 69: 120-131.
32. Hislop JN, von Zastrow M, (2011). Role of ubiquitination in endocytic trafficking of G-protein-coupled receptors. Traffic 12: 137-148.
33. Holdridge SV, Cahill CM, (2007). Spinal administration of a delta opioid receptor agonist attenuates hyperalgesia and allodynia in a rat model of neuropathic pain. Eur J Pain 11: 685-693.
34. Holdridge SV, Armstrong SA, Taylor AMW, Cahill CM, (2007). Behavioural and morphological evidence for the involvement of glial cell activation in delta opioid receptor function: implications for the development of opioid tolerance. Mol Pain 3: 7.
35. Hong M-H, Xu C, Wang Y-J, Ji J-L, Tao Y-M, Xu X-J, et al. (2009). Role of Src in ligand-specific regulation of delta-opioid receptor desensitization and internalization. J Neurochem 108: 102-114.
36. Jordan BA, Devi LA, (1999). G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399: 697-700.
37. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010). Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160: 1577-1579.
38. Kim JA, Bartlett S, He L, Nielsen CK, Chang AM, Kharazia V, et al. (2008). Morphine-induced receptor endocytosis in a novel knockin mouse reduces tolerance and dependence. Curr Biol 18: 129-135.
39. Law P-Y, Erickson-Herbrandson LJ, Zha QQ, Solberg J, Chu J, Sarre A, et al. (2005). Heterodimerization of mu- and delta-opioid receptors occurs at the cell surface only and requires receptor-G protein interactions. J Biol Chem 280: 11152-11164.
40. Law PY, Loh HH, (1999). Regulation of opioid receptor activities. J Pharmacol Exp Ther 289: 607-624.
41. Lucido AL, Morinville A, Gendron L, Stroh T, Beaudet A, (2005). Prolonged morphine treatment selectively increases membrane recruitment of delta-opioid receptors in mouse basal ganglia. J Mol Neurosci 25: 207-214.
42. Marie N, Lecoq I, Jauzac P, Allouche S, (2003). Differential sorting of human delta-opioid receptors after internalization by peptide and alkaloid agonists. J Biol Chem 278: 22795-22804.
43. Martini L, Whistler JL, (2007). The role of mu opioid receptor desensitization and endocytosis in morphine tolerance and dependence. Curr Opin Neurobiol 17: 556-564.
44. McGrath JC, Drummond GB, McLachlan EM, Kilkenny C, Wainwright CL, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
45. McLamore S, Ullrich T, Rothman RB, Xu H, Dersch C, Coop A, et al. (2001). Effect of N-alkyl and N-alkenyl substituents in noroxymorphindole, 17-substituted-6,7-dehydro-4,5α-epoxy-3,14-dihydroxy-6,7:2′,3′-indolomorphinans, on opioid receptor affinity, selectivity, and efficacy. J Med Chem 44: 1471-1474.
46. Milan-Lobo L, Whistler JL, (2011). Heteromerization of the μ- and δ-opioid receptors produces ligand-biased antagonism and alters μ-receptor trafficking. J Pharmacol Exp Ther 337: 868-875.
47. Morinville A, Cahill CM, Esdaile MJ, Aibak H, Collier B, Kieffer BL, et al. (2003). Regulation of delta-opioid receptor trafficking via mu-opioid receptor stimulation: evidence from mu-opioid receptor knock-out mice. J Neurosci 23: 4888-4898.
48. Morinville A, Cahill CM, Aibak H, Rymar VV, Pradhan A, Hoffert C, et al. (2004a). Morphine-induced changes in delta opioid receptor trafficking are linked to somatosensory processing in the rat spinal cord. J Neurosci 24: 5549-5559.
49. Morinville A, Cahill CM, Kieffer B, Collier B, Beaudet A, (2004b). Mu-opioid receptor knockout prevents changes in delta-opioid receptor trafficking induced by chronic inflammatory pain. Pain 109: 266-273.
50. Nagi K, Piñeyro G, (2011). Regulation of opioid receptor signalling: implications for the development of analgesic tolerance. Mol Brain 4: 25.
51. Petaja-Repo UE, Hogue M, Laperriere A, Walker P, Bouvier M, (2000). Export from the endoplasmic reticulum represents the limiting step in the maturation and cell surface expression of the human delta opioid receptor. J Biol Chem 275: 13727-13736.
52. Petaja-Repo UE, Hogue M, Laperriere A, Bhalla S, Walker P, Bouvier M, (2001). Newly synthesized human delta opioid receptors retained in the endoplasmic reticulum are retrotranslocated to the cytosol, deglycosylated, ubiquitinated, and degraded by the proteasome. J Biol Chem 276: 4416-4423.
53. Petäjä-Repo UE, Hogue M, Bhalla S, Laperrière A, Morello J-P, Bouvier M, (2002). Ligands act as pharmacological chaperones and increase the efficiency of delta opioid receptor maturation. EMBO J 21: 1628-1637.
54. Petäjä-Repo UE, Hogue M, Leskelä TT, Markkanen PMH, Tuusa JT, Bouvier M, (2006). Distinct subcellular localization for constitutive and agonist-modulated palmitoylation of the human delta opioid receptor. J Biol Chem 281: 15780-15789.
55. Piñeyro G, Archer-Lahlou E, (2007). Ligand-specific receptor states: implications for opiate receptor signalling and regulation. Cell Signal 19: 8-19.
56. Portoghese PS, Lunzer MM, (2003). Identity of the putative delta1-opioid receptor as a delta-kappa heteromer in the mouse spinal cord. Eur J Pharmacol 467: 233-234.
57. Pradhan AAA, Walwyn W, Nozaki C, Filliol D, Erbs E, Matifas A, et al. (2010). Ligand-directed trafficking of the δ-opioid receptor in vivo: two paths toward analgesic tolerance. J Neurosci 30: 16459-16468.
58. Rozenfeld R, Abul-Husn NS, Gomez I, Devi LA, (2007). An emerging role for the delta opioid receptor in the regulation of mu opioid receptor function. Scientificworldjournal 7: 64-73.
59. Scherrer G, Imamachi N, Cao Y-Q, Contet C, Mennicken F, O'Donnell D, et al. (2009). Dissociation of the opioid receptor mechanisms that control mechanical and heat pain. Cell 137: 1148-1159.
60. Southern C, Cook JM, Neetoo-Isseljee Z, Taylor DL, Kettleborough CA, Merritt A, et al. (2013). Screening β-arrestin recruitment for the identification of natural ligands for orphan G-protein-coupled receptors. J Biomol Screen 18: 599-609.
61. Tanowitz M, von Zastrow M, (2002). Ubiquitination-independent trafficking of G protein-coupled receptors to lysosomes. J Biol Chem 277: 50219-50222.
62. Waldhoer M, Fong J, Jones RM, Lunzer MM, Sharma SK, Kostenis E, et al. (2005). A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers. Proc Natl Acad Sci U S A 102: 9050-9055.
63. Walwyn W, John S, Maga M, Evans CJ, Hales TG, (2009). Delta receptors are required for full inhibitory coupling of mu-receptors to voltage-dependent Ca(2+) channels in dorsal root ganglion neurons. Mol Pharmacol 76: 134-143.
64. Wang H-B, Guan J-S, Bao L, Zhang X, (2008). Distinct subcellular distribution of delta-opioid receptor fused with various tags in PC12 cells. Neurochem Res 33: 2028-2034.
65. Wang H-B, Zhao B, Zhong Y-Q, Li K-C, Li Z-Y, Wang Q, et al. (2010). Coexpression of delta- and mu-opioid receptors in nociceptive sensory neurons. Proc Natl Acad Sci U S A 107: 13117-13122.
66. Whistler JL, Enquist J, Marley A, Fong J, Gladher F, Tsuruda P, et al. (2002). Modulation of postendocytic sorting of G protein-coupled receptors. Science 297: 615-620.
67. Williams JT, Ingram SL, Henderson G, Chavkin C, Zastrow M, von Schulz S, et al. (2013). Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance. Pharmacol Rev 65: 223-254.
68. von Zastrow M, (2010). Regulation of opioid receptors by endocytic membrane traffic: mechanisms and translational implications. Drug Alcohol Depend 108: 166-171.
69. Zhu Y, King MA, Schuller AG, Nitsche JF, Reidl M, Elde RP, et al. (1999). Retention of supraspinal delta-like analgesia and loss of morphine tolerance in delta opioid receptor knockout mice. Neuron 24: 243-252.
70. Zuo Z, (2005). The role of opioid receptor internalization and beta-arrestins in the development of opioid tolerance. Anesth Analg 101: 728-734, table of contents.